Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SATISFY-JP, a phase II multicenter open-label study on Satralizumab, an anti-IL-6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune-responsive-phenotype: Study protocol.
Tamura Y, Takeyasu R, Takata T, Miyazaki N, Takemura R, Wada M, Tamura Y, Abe K, Shigeta A, Taniguchi Y, Adachi S, Inami T, Tsujino I, Tahara N, Kuwana M. Tamura Y, et al. Among authors: kuwana m. Pulm Circ. 2023 Jun 19;13(2):e12251. doi: 10.1002/pul2.12251. eCollection 2023 Apr. Pulm Circ. 2023. PMID: 37342675 Free PMC article.
Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.
Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J, Kato H, Hato T, Tomiyama Y; Committee for Reference Guide for diagnosis of adult ITP Research Team for Coagulopathy and Other Intractable Diseases supported by the Ministry of Health, Labor and Welfare Science Research Grant Project: Research on Health Care Policy for Intractable Diseases. Kashiwagi H, et al. Among authors: kuwana m. Int J Hematol. 2024 Jan;119(1):1-13. doi: 10.1007/s12185-023-03672-1. Epub 2023 Nov 13. Int J Hematol. 2024. PMID: 37957517 Free PMC article.
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study).
Tamura Y, Kumamaru H, Tsujino I, Suda R, Abe K, Inami T, Horimoto K, Adachi S, Yasuda S, Sera F, Taniguchi Y, Kuwana M, Tatsumi K; Japan Pulmonary Hypertension Registry Network. Tamura Y, et al. Among authors: kuwana m. Pharmaceuticals (Basel). 2024 Apr 26;17(5):555. doi: 10.3390/ph17050555. Pharmaceuticals (Basel). 2024. PMID: 38794126 Free PMC article.
Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry.
Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K; JRPHS Group. Tanabe N, et al. Among authors: kuwana m. JACC Asia. 2024 Mar 26;4(5):403-417. doi: 10.1016/j.jacasi.2024.01.009. eCollection 2024 May. JACC Asia. 2024. PMID: 38765657 Free PMC article.
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Kuwana M, Joshi M, Gracia-Ramos AE, Boyd P, Yaadav P, Cheng K, Kobert L, Cavagna L, Sen P, Day J, Makol A, Gutiérrez CET, Caballero-Uribe CV, Saha S, Parodis I, Dey D, Nikiphorou E, Distler O, Kadam E, Tan AL, Shinjo SK, Ziade N, Knitza J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD Study Group. Shumnalieva R, et al. Among authors: kuwana m. Int J Rheum Dis. 2024 May;27(5):e15178. doi: 10.1111/1756-185X.15178. Int J Rheum Dis. 2024. PMID: 38742751
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D, Cavagna L, Makol A, Gutiérrez CET, Caballero Uribe CV, Kuwana M, Burmester GR, Ziade N, Wincup C, Andreoli L, Parodis I, Tan AL, Guillemin F, Knitza J, Wang G, Dalbeth N, Velikova T, Gracia-Ramos AE, Nikiphorou E, Day J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD study group. Joshi M, et al. Among authors: kuwana m. Int J Rheum Dis. 2024 May;27(5):e15161. doi: 10.1111/1756-185X.15161. Int J Rheum Dis. 2024. PMID: 38720408
The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial.
Inoue Y, Kitamura H, Okamoto M, Ogura T, Nishioka Y, Kuwana M, Taniguchi A, Ito T, Rohr KB, Suda T. Inoue Y, et al. Among authors: kuwana m. Respir Investig. 2024 Apr 30;62(4):589-596. doi: 10.1016/j.resinv.2024.04.008. Online ahead of print. Respir Investig. 2024. PMID: 38692040 Free article.
554 results